<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03591939</url>
  </required_header>
  <id_info>
    <org_study_id>TRD</org_study_id>
    <nct_id>NCT03591939</nct_id>
  </id_info>
  <brief_title>T-regulatory Cells in Diabetic Type Two Nephropathy</brief_title>
  <official_title>Role of T-regulatory Cells in Type Two Diabetic Nephropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes mellitus is one of the most prevalent health problems worldwide. Diabetic
      nephropathy has become the leading cause of end-stage kidney disease worldwide and is
      associated with an increased cardiovascular risk.

      Traditionally, metabolic and hemodynamic factors are the main causes of renal lesions in
      patients with type two diabetes mellitus and diabetic nephropathy , both considered
      non-immune diseases. Serial researches has demonstrated that diabetic nephropathy is a
      metabolic and hemodynamic disorder, with inflammation playing a vital role in the process.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It has been reported that glomerular basement membranes from diabetic rats induced
      significantly greater amounts of Tumor necrotic factor-alpha and Interleukin-1 than when
      these cells were incubated with basement membranes from non-diabetic rats.

      These new findings were the first to suggest that inflammatory cytokines may participate in
      the pathogenesis of diabetic nephropathy .Cluster of differentiation 4 cells are believed to
      play central roles in modulating immune responses. Tumor necrotic factor-alpha and
      Interleukin-6, and induce inflammation in the pathogenesis of autoimmune diseases.

      T- regulatory cells exert immunosuppressive effects which are important on the maintenance of
      immune homeostasis by producing anti-inflammatory cytokines, such as Interleukin-10 and
      transforming growth factor-b.

      Aim of this work is to the role of T regulatory cells :( Cluster of differentiation 4,
      Cluster of differentiation 25,Cluster of differentiation 127 , forkhead box P3 cells) in the
      different stages of diabetic nephropathy before hemodialysis initiation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">August 1, 2018</start_date>
  <completion_date type="Anticipated">October 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>rate of patients with positive T-regulatory cells in blood</measure>
    <time_frame>one week</time_frame>
    <description>number of patients with diabetic type two nephropathy with positive T-regulatory cells in blood</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Diabetic Nephropathy Type 2</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>cases of Diabetic type two nephropathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>controls of normal subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>laboratory test</intervention_name>
    <description>role of T- regulatory cells in the patients of diabetic nephropathy</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        subjects will be collected in a questionnaire form; from outpatient clinic in Assiut
        University hospital .These will be included in a file sheet for each subject : Age, Sex,
        Body height, weight and body mass index,Special habits ,fundus examination and neurological
        examination ,Blood pressure, pulse ,General and systematic examination Investigations will
        include; urine analysis, blood urea and serum creatinine, complete blood count, Fasting and
        2 h post pranidal glucose levels
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult patients above 20 years diagnosed with type 2 diabetes mellitus and have
        microalbuminuria, macroalbuminuria or renal impairment

        Exclusion Criteria:

        Patients with ischemic heart disease, any other autoimmune diseases, and Hepatitis C or B
        positive patients.

        b-Patients with diabetic nephropathy on dialysis therapy c- Patients with any other causes
        for renal diseases such as glomerulonephritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Muhammed Hossam Maghraby, professor</last_name>
    <phone>00201020671222</phone>
    <email>hossammaghraby@med.au.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Walaa Hosny Hosny Muhammed, lecturer</last_name>
    <phone>00201005220944</phone>
    <email>walaa.hosny2012@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest. 2004 Dec;34(12):785-96. Review.</citation>
    <PMID>15606719</PMID>
  </reference>
  <reference>
    <citation>Rivero A, Mora C, Muros M, García J, Herrera H, Navarro-González JF. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond). 2009 Mar;116(6):479-92. doi: 10.1042/CS20080394. Review.</citation>
    <PMID>19200057</PMID>
  </reference>
  <reference>
    <citation>Hasegawa G, Nakano K, Sawada M, Uno K, Shibayama Y, Ienaga K, Kondo M. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int. 1991 Dec;40(6):1007-12.</citation>
    <PMID>1762301</PMID>
  </reference>
  <reference>
    <citation>Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol. 2004 Jul;4(7):553-64. doi: 10.1038/nri1394. Review.</citation>
    <PMID>15229474</PMID>
  </reference>
  <reference>
    <citation>Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008 Apr;127(1):89-97. doi: 10.1016/j.clim.2008.01.009. Epub 2008 Feb 21. Erratum in: Clin Immunol. 2009 Dec;133(3):447.</citation>
    <PMID>18294918</PMID>
  </reference>
  <reference>
    <citation>Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006 Aug;212:8-27. Review.</citation>
    <PMID>16903903</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 8, 2018</study_first_submitted>
  <study_first_submitted_qc>July 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>July 8, 2018</last_update_submitted>
  <last_update_submitted_qc>July 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>HSGalal</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Diabetic Nephropathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

